You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
16 January 2026 - US-based digital health company Profusa, Inc. (NASDAQ: PFSA), which develops tissue-integrated biosensors for continuous biochemical monitoring, announced on Friday the launch of a healthcare research version of its Lumee tissue oxy...
16 January 2026 - China-based medical technology company Zylox-Tonbridge Medical Technology Co., Ltd. (HKEX: 2190) said on Friday that it has entered into a definitive agreement to acquire Germany-based Optimed Medizinische Instrumente GmbH in multip...
16 January 2026 - OncoHost, a technology company focused on precision medicine, announced on Monday that the Business Intelligence Group has named OncoHost as a winner in the 2026 BIG Innovation Awards in the Health category.Additionally, OncoHost wa...
16 January 2026 - Hoth Therapeutics Inc (NASDAQ:HOTH), a US-based clinical-stage biopharmaceutical company, announced on Thursday that it has achieved a major European regulatory milestone for its HT-001 clinical programme, targeting cancer patients ...
16 January 2026 - Zydus Lifesciences Limited, an India-based life-sciences company, announced on Thursday that it has completed an Asset Purchase Agreement, Share Purchase Agreement, and exclusive Licensing Agreement with Agenus Inc (NASDAQ:AGEN), a ...
15 January 2026 - French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) announced on Thursday that China's National Medical Products Administration has approved two Sanofi-licensed medicines: Myqorzo (aficamten) for the treatme...
15 January 2026 - US-based AVEO Oncology, an LG Chem (KRX:051910) company, announced on Wednesday that the first patient has been successfully dosed in a Phase 1b/2 clinical trial evaluating ficlatuzumab in combination with azacitidine and venetoclax...